Page 628 - Read Online
P. 628

Wilgus. Plast Aesthet Res 2020;7:54  I  http://dx.doi.org/10.20517/2347-9264.2020.150                                            Page 7 of 18

               The role of mast cells in scar formation has also been examined in mast cell-deficient mouse strains (either
               naturally occurring mutants or genetically modified mice), and the results seem to differ depending on the
               mouse strain and wound model used. Kit W/W-v  mice are mutant mice that lack mast cells due to functional
               mutations in the tyrosine kinase receptor c-kit, which binds an important growth factor for mast cells
                                           [74]
               (stem cell factor). Younan et al.  used these mice in a study looking at the effects of microdeformation
               in wounds using a negative pressure wound therapy device. They showed that microdeformation induced
               higher levels of mast cell degranulation, which correlated with an increase in granulation tissue thickness
               and collagen deposition. These changes were normalized in Kit W/W-v  mice, suggesting that the increases in
               granulation tissue and collagen production from the microdeformation device were mast cell-dependent.
               Kit W/W-v  mice were also shown to heal with smaller scars in late-gestation fetal skin wounds compared to
                                                                              [75]
                          [53]
               control mice  and less fibrosis at the wound edge in adult scald wounds , supporting the idea that mast
               cells promote scar formation and fibrosis. In contrast to these studies, several other mast cell-deficient
               mouse strains have been shown to heal with similar levels of scar tissue and collagen deposition compared
               to control mice that have normal mast cell numbers [76-78] . Many of the published studies discussed above
               used different wound models and different mast cell-deficient strains, which could partially explain the
               variable results. In addition, most mast cell-deficient strains also have defects in one or more other immune
               cell types and non-specifically deplete the entire mast cell population, so it will be important to revisit these
               ideas once we understand more about mast cell heterogeneity and have more precise mouse models to
                                                                                  [79]
               specifically target mast cells and possibly different functional mast cell subtypes .
               Neutrophils and macrophages
               Several mutant mouse strains have been used to examine the importance of neutrophils and macrophages
               in wound-induced scar formation. One of the first studies of this kind explored wound healing in
               mice lacking the transcription factor PU.1 . PU.1 null mice, which lack macrophages and functional
                                                     [80]
               neutrophils, were shown to heal quickly and with minimal scarring. However, the relative importance of
               macrophages versus neutrophils is unclear since both cell types are absent in wounds from PU.1 null mice.
               While some studies suggest that the early neutrophil response may be important for scar formation and the
               presence of neutrophil extracellular traps have been reported in skin scars and other fibrotic conditions ,
                                                                                                       [81]
               there do not appear to be published studies examining scar formation using animal models in which
               neutrophils have been specifically depleted.

               More specific studies examining the role of macrophages in collagen deposition and scar formation have
               been performed using several approaches. Studies from two groups have used slightly different genetically
                                                                                                        [82]
               modified mouse strains in combination with diphtheria toxin to deplete macrophages. Mirza et al.
                                                                                                 [83]
               showed reduced collagen density in wounds from macrophage-depleted mice and Lucas et al.  showed
               that depletion of macrophages at early stages of wound healing reduced the amount of granulation
               tissue and the size of scars that formed. Several studies have also used clodronate liposomes to deplete
               macrophages. One study showed that macrophage depletion reduced collagen expression and deposition
                        [84]
               in wounds  and another showed that macrophage depletion reduced scar formation in a xenograft model
               of HTS . While it is generally accepted that macrophages release mediators that can stimulate collagen
                      [85]
               production by fibroblasts, several recent studies have suggested the possibility of novel mechanisms. For
               example, macrophages were shown to support adipocyte-derived myofibroblasts through insulin-like
                                                            [86]
               growth factor and platelet-derived growth factor C . A recent report also highlighted the plasticity of
                                                                                                       [87]
               myeloid cells, which may be converted directly to collagen-producing fibroblasts in healing wounds .
               More work will have to be done to understand exactly how macrophages contribute to scar formation.

               Inflammatory mediators
               Aside from specific inflammatory cell types, a wide range of inflammatory mediators, including both pro-
               and anti-inflammatory mediators, have been shown to play a functional role in cutaneous scar formation.
   623   624   625   626   627   628   629   630   631   632   633